首页> 外文期刊>Australian Veterinary Journal >Pharmacokinetics of carprofen and firocoxib for medication control in racing greyhounds
【24h】

Pharmacokinetics of carprofen and firocoxib for medication control in racing greyhounds

机译:乘坐赛车猎犬和萤火虫药代动力学

获取原文
获取原文并翻译 | 示例
           

摘要

Animals used in sport should be treated as required to ensure animal welfare but any such use of medication should also be controlled to ensure integrity. Pharmacokinetic studies on groups of six greyhounds were performed to measure plasma and urine levels of carprofen and firocoxib to inform medication control advice. Using the standard methodology for medication control the Irrelevant Plasma Concentration was determined as 20 and 2 ng/mL for carprofen and firocoxib, respectively. The Irrelevant Urine Concentration was also determined as 0.3 and 2 ng/mL for carprofen and firocoxib, respectively. These Irrelevant Plasma and Urine Concentrations will allow laboratory Screening Limits, Detection Times and Withdrawal Time advice to be determined and publicised by regulators of greyhound racing. The Screening Limits will also inform Recommended Limits of Detection if meat-containing residues of these medications are fed to greyhounds.
机译:运动中使用的动物应根据需要治疗,以确保动物福利,但也应控制任何这种药物使用,以确保完整性。 对六个灰狗组的药代动力学研究进行了测量血浆和尿释布的血浆和尿液水平,以通知药物控制建议。 使用标准的药物控制方法,分别测定不相关的等离子体浓度为储物丁香和呋喃酮的20和2ng / ml。 对于储物和呋喃酮,也确定无关尿液浓度也确定为0.3和2ng / ml。 这些不相关的血浆和尿液浓度将允许通过Greyhound Racing的监管机构确定和公布的实验室筛选限制,检测时间和戒断时间建议。 如果将含肉残留物送入灰猎犬,筛选限制也将推荐推荐的检测限估计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号